Patricia L Allen has an estimated net worth of $2.84 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Deciphera Pharmaceuticals, Inc., ZAFGEN, INC., YUMANITY THERAPEUTICS, INC., and Zenas BioPharma, Inc..

2020 was Patricia L Allen's most active year for acquiring shares with 7 total transactions. Patricia L Allen's most active month to acquire stocks was the month of May. 2007 was Patricia L Allen's most active year for disposing of shares, totalling 52 transactions. Patricia L Allen's most active month to dispose stocks was the month of September. 2020 saw Patricia L Allen paying a total of $407,510.00 for 91,766 shares, this is the most they've acquired in one year. In 2020 Patricia L Allen cashed out on 49,000 shares for a total of $2,344,773.50, their largest year based on trade value.